Dov A MD Goldstein's Net Worth

$1.27 Million

Estimate Recalculated Nov 1, 2024 04:52AM EST

Who is Dov A MD Goldstein?

Dov A MD Goldstein has an estimated net worth of $1.27 Million. This is based on reported shares across multiple companies, which include VERSICOR INC, CEMPRA, INC., Esperion Therapeutics, Inc., R&R ACQUISITION VI, INC, Loxo Oncology, Inc., NeuBase Therapeutics, Inc., Coya Therapeutics, Inc., Gain Therapeutics, Inc., Durata Therapeutics, Inc., and VICURON PHARMACEUTICALS INC.

SEC CIK

Dov A MD Goldstein's CIK is 0001120478

Past Insider Trading and Trends

2015 was Dov A MD Goldstein's most active year for acquiring shares with 11 total transactions. Dov A MD Goldstein's most active month to acquire stocks was the month of May. 2015 was Dov A MD Goldstein's most active year for disposing of shares, totalling 10 transactions. Dov A MD Goldstein's most active month to dispose stocks was the month of May. 2015 saw Dov A MD Goldstein paying a total of $278,877.57 for 125,217 shares, this is the most they've acquired in one year. In 2015 Dov A MD Goldstein cashed out on 144,059 shares for a total of $1,787,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

VERSICOR INC No price found

CHIEF FINANCIAL OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
No matching records found

CEMPRA, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-150.00K
$3.55
-$533,115.84
0
Mar 7 - Mar 8
Form 4
—
0
—
—
0
Jan 3
Form 4
-41.28%
-105.46K
$3.40
-$358,564.00
150K
Jan 13
Form 4
-78.59%
-937.60K
$3.41
-$3,192,864.00
255.46K
Jan 5 - Jan 6
Form 4
-45.60%
-1.00M
—
—
1.19M
Mar 7
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
$30.06
-$25,314.48
50
Scheduled
Jun 22 - Jan 4
Form 4
—
0
$35.74
-$1,787,000.00
50
Scheduled
Jun 22
Form 4
-33.40%
-1.10M
—
—
2.19M
May 14
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Jan 8
Form 4
—
0
—
—
0
Feb 4
Form 4
—
0
—
—
0
Mar 20
Form 4
+58.37%
1.21M
$6.00
$7,281,978.00
3.29M
Feb 7
Form 3
—
0
—
—
0
No matching records found

Esperion Therapeutics, Inc. (ESPR) Snapshot price: $1.69

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$16.47
$214,100.00
47
Jun 6
Form 4
—
0
—
—
0
May 23
Form 4
—
0
$3.70
$79,442.70
47
Dec 18
Form 4
+422.22%
38
—
—
47
Dec 5
Form 4
—
0
—
—
0
Apr 17
Form 4
-48.87%
-800.00K
$41.66
-$33,327,088.28
837.13K
Mar 21 - Mar 22
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
May 14
Form 4
-10.89%
-199.99K
—
—
1.64M
Apr 28
Form 4
-10.58%
-217.47K
$108.22
-$23,534,372.60
1.84M
Apr 23 - Apr 24
Form 4
—
0
—
—
0
May 15
Form 4
∞
2.05M
$14.00
—
2.05M
Jul 1
Form 3
—
0
—
—
0
No matching records found

R&R ACQUISITION VI, INC (ADMA) Snapshot price: $16.99

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
∞
7.5K
—
—
7.5K
Feb 28
Form 4
∞
7.5K
—
—
7.5K
Feb 28
Form 4
—
0
—
—
0
Mar 13
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Feb 14
Form 4
—
0
—
—
0
Jan 28
Form 4
—
0
—
—
0
Jan 30
Form 4
—
0
—
—
0
Jun 19
Form 4
—
0
—
—
0
Apr 4
Form 4
∞
2.52M
—
—
2.52M
Feb 13
Form 3
—
0
—
—
0
No matching records found

Loxo Oncology, Inc. No price found

CFO and Treasurer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+190.75%
43.22K
$6.45
$278,877.57
65.87K
Apr 1 - Apr 2
Form 3/A
—
0
—
—
0
Form 4
+1,729.55%
3.26M
$13.00
$5,370,001.00
3.45M
Aug 6
Form 4
+1,729.55%
3.26M
$13.00
$5,370,001.00
3.45M
Aug 6
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found